Why do some individuals succumb to stress and develop debilitating psychiatric disorders, whereas others adapt well in the face of adversity? There is a gap in understanding the neural bases of individual differences in the responses to environmental factors on brain development and functions. Here, using a novel approach for screening an inbred population of laboratory animals, we identified two subpopulations of mice: susceptible mice that show mood-related abnormalities compared with resilient mice, which cope better with stress. This approach combined with molecular and behavioral analyses, led us to recognize, in hippocampus, presynaptic mGlu2 receptors, which inhibit glutamate release, as a stress-sensitive marker of individual differences to stressinduced mood disorders. Indeed, genetic mGlu2 deletion in mice results in a more severe susceptibility to stress, mimicking the susceptible mouse sub-population. Furthermore, we describe an underlying mechanism by which glucocorticoids, acting via mineralocorticoid receptors (MRs), decrease resilience to stress via downregulation of mGlu2 receptors. We also provide a mechanistic link between MRs and an epigenetic control of the glutamatergic synapse that underlies susceptibility to stressful experiences. The approach and the epigenetic allostasis concept introduced here serve as a model for identifying individual differences based upon biomarkers and underlying mechanisms and also provide molecular features that may be useful in translation to human behavior and psychopathology.
INTRODUCTION
It is well known that identical twins differ as they mature in behavior, physiology and susceptibility to disease. This is reflected in patterns of DNA methylation that diverge as a result of nonshared experiences as the lifecourse unfolds. 1 Recently, Freund et al. 2 showed that genetically identical mice, living in an enriched environment, displayed differences in exploratory activity that diverged over time, resulting in increasing individual differences that correlated positively with individual differences in adult hippocampal neurogenesis. Furthermore, individual differences in anxiety-like behaviors among genetically similar rats, living in the same environments and not previously exposed to experimental manipulations, have been shown to predict lifespan 3 and prefrontal cortical dendritic length. 4 Stressful experiences superimposed on top of such individual differences can lead 5, 6 to susceptible individuals developing debilitating stress-related mental and physical health disorders; 7-9 whereas more resilient individuals are able to recover from the same stressors or do not respond to it in the first place, 10 displaying cognitive flexibility. 11 However, there is a gap in understanding how the hippocampus and prefrontal cortex (PFC), which are involved in the pathophysiology of mood-related behaviors, integrate the molecular processes of stress responsivity, conferring a different individual susceptibility to psychopathologies. 12 Moreover, individual differences in stress sensitivity can have direct effects on the response to pharmacological agents. Stressful events can also precipitate psychopathological episodes in susceptible individuals and aggravate an individual's predisposition for suicidal ideation. 13, 14 Thus, understanding the molecular bases of individual stress responsiveness paves the way to a better understanding of individual differences in brain function that subserve successful vs unsuccessful coping. In the case of susceptible individuals, this may provide a mechanistic basis for developing rapidly acting pharmaceutical agents that, together with psychotherapy, will improve mood and reduce the probability of suicide as well as improve the quality of life.
Glutamate, the principal neurotransmitter of the mammalian brain, has a major role not only in normal brain function but also in the pathophysiology of stress-related mental and neurological disorders. 15 Indeed, glutamate homeostasis is mainly regulated by presynaptic mGlu2 receptors, which exert an inhibitory tone on glutamate release into the synaptic space. Recently, we showed that mGlu2 receptors are involved in stress-related disorders and in the mechanisms of action of antidepressant drugs. 16 Patients with major depressive disorder show a positive correlation between increased glutamate serum levels 17 and the severity of depressive symptoms. 18 It is also known that stress-induced dysregulation of glutamate release leads to shrinking of dendrites in CA3 neurons, loss of spines in the CA1 region and suppression of dentate gyrus neurogenesis, reinforcing the importance of regulating hippocampal glutamatergic activity. 19 Here we addressed the intriguing question as to whether differences in mGlu2 receptors may be involved in the individuality of the brain response to stress. Previously, we discovered that the depressive-like behavior of Flinders sensitive line rats, a genetic animal model of depression, 20 is associated with a selective epigenetically induced downregulation of mGlu2 receptors, and that mGlu2-knockout mice fail to respond to the recently recognized rapidly acting antidepressant candidate, acetyl-Lcarnitine. 16, 21, 22 Based upon this, we hypothesized that wild-type mice might differ in their individual susceptibility to stressors and those mice which are more susceptible might have lower mGlu2 levels. First, we used a chronic unpredictable stressor (CUS), in which we previously showed efficacy of acetyl-L-carnitine in preventing depressive-like behavior, 16 to assess individual differences in mGlu2 receptor expression and in mood-related behavioral traits. We found a subset of wild-type mice showing more depressive-like behavior after CUS with lower mGlu2 expression compared with other mice that were much less affected by CUS and which had higher mGlu2 expression. We then devised a simple, acute screening method for rapidly identifying susceptible vs resilient animals using minimal stress. Finally, we asked whether adrenal steroids, which participate in positive as well as negative actions of stress on the brain 15, 23, 24 would play a key role in the epigenetic regulation of mGlu2 receptors via mineralocorticoid (MR) and/or glucocorticoid receptors (GRs).
MATERIALS AND METHODS Animals
Male C57 black mice (6-week old, 20-25 g) and mGlu2 receptor-knockout mice were housed five per cage under controlled conditions (12-h-light/dark cycle, 22°C, food and water ad libitum); they were individually gently handled daily for 1 week before the beginning of the stress procedures. Once a week, body weights were recorded and the condition of their coat and eye conjunctiva was evaluated according to the coat-state rating scale (detailed in Supplementary Information and Supplementary Table 1 ) by two independent observers before the start of each behavioral test session.
We developed a novel and acute novel approach to subdivide animals in high-susceptible (HS) and low-susceptible (LS) clusters. The following statistical approach was used for the assignment of mice to HS and LS clusters. Mice subjected to CUS were divided into HS and LS subpopulations based on their immobility time at the forced swim test (FST) and their sucrose intake. CUS-treated mice, which fell into the standard deviation from the mean of the control group, were considered LS animals as they showed a behavior comparable with unstressed mice. Animals that fell outside the standard deviation of the mean of the control group were designated as HS mice.
Similarly, in the evaluation of mice after the light-dark test (LDT), mice falling inside and outside the standard deviation from the mean of the control group were, respectively, designated as LS and HS mice. This was done for mice in the acute restraint stress (ARS) experiment and also for naïve mice after the LDT without prior acute stress.
Treatments
The selective MR antagonist, spironolactone (20 mg kg − 1 intraperitoneal (i.p.), Sigma Aldrich, St Louis, MO, USA), and the selective GR antagonist mifepristone (20 mg kg − 1 i.p., formerly known as RU486, Sigma Aldrich) were injected i.p. 3 h before the ARS as schematized in Figure 1a . The doses were selected on the basis of previously published reports. 25 
Stress procedures
Chronic unpredictable stress was performed as detailed in Figure 2a and b. Mice were subjected two times daily for 28 days to two different stressors accordingly to a random schedule to avoid any kind of habituation. Tissues were collected 12 h after the last episode of stress. The different types of stressor used are detailed in the table in Figure 2b . Control mice were left undisturbed in their home cages until killed, except for the body weight measurement and behavioral tests.
For the acute stress procedure, naïve C57bl mice were stressed for 2 h followed by 2-h recovery in their home cages before the light-dark behavior test and killed 15 min later as schematized in Figure 3a . The restraint device contained a 0.4-cm air hole and allowed mice to stretch their legs but not to move within the tube. Age-matched animals were used as control for each group. Control mice were left undisturbed in their home cage until the behavioral test followed by killing ( Figure 3a ). For gene analysis by reverse transcriptase-PCR, after rapid decapitation, hippocampal and PFC tissues were dissected, flash-frozen and stored at − 80°C until processing.
Additional naïve C57bl mice were not stressed and were screened using the LDT. Then, 15 min after the LDT, mice were killed to collect brains for dissection of hippocampus and reverse transcriptase-PCR ( Figure 4e ).
Behavioral tests
FST. The duration of immobility at the FST was scored by blind observers, who were not aware of the groups. Mice were placed individually into a vertical glass cylinder (25 cm in height and 12 cm in diameter) filled with 12-cm deep water at 23-24°C. A 15-min pretest (habituation session) was carried out 24 h before the first test session. In each test session, animals were placed in the cylinder for 5 min and videotaped. Mice were considered 'immobile' if they showed only minimal movements to keep the head above water or floating.
Sucrose preference test. The sucrose preference test has been performed as previously described. 16 Mice were given a free choice between two bottles, one with 2% sucrose solution and another with water, for 24 h (Supplementary Information). To prevent possible effects of side preference in drinking behavior, the position of the bottles was switched after 12 h. No previous food or water deprivation was applied before the test. The consumption of water and sucrose solution was estimated in control and experimental groups by weighing the bottles.
LDT. The LDT was performed as previously described. 26 The apparatus consisted of a rectangular Plexiglas box (20 × 50 × 20 cm) with a black chamber comprising 1\3 of the total volume. The two chambers were separated by a Plexiglas septum with an open door (12 × 5 cm) that permitted the passage from the illuminated chamber (400 lx) to the enclosed dark chamber (4 Ix). Mice were videotaped, and the time spent by each mouse in the light chamber was measured. Mice were considered to have entered a chamber when all four paws were positioned into the chamber. No pretest (habituation session) was carried out before the test session.
Molecular procedures
Gene expression, western blot and chromatin immunoprecipitation methods were performed as previously described. 20 Details in Supplementary Information.
Statistics
Statistical analyses were performed using the two-tailed unpaired Student's t-tests (for comparison of two groups), one-way analysis of variances followed by Tukey's test for the post hoc analysis (for three groups) and one-way repeated-measure analysis of variances. Correlations between the behavioral tests were analyzed by Spearman's correlation.
RESULTS
mGlu2-knockout mice show a higher susceptibility to CUS Previously, we showed that mGlu2-knockout mice fail to respond to the newly recognized rapid antidepressant candidate, acetyl-Lcarnitine. 16, 21, 22 Here, we determined whether a genetic depletion in mGlu2 receptors may be involved in the behavioral response to stress and whether there are individual differences in wild-type mice in response to chronic unpredictable stress (CUS, Figure 1a and b). This stress paradigm has face validity in its ability to model the symptoms of stress-related disorders. 27 We subjected C57 black and mGlu2-knockout mice on the same background to CUS. Importantly, mGlu2-knockout mice subjected to CUS show a higher immobility time at the FST (Figure 1c ) as well as a lower weight gain ( Figure 1d ) and a severe deterioration of the coat at the coat-state rating scale ( Figure 1e ) compared with wild-type CUS mice.
Chronic unpredictable stress results in HS and LS endophenotypes
We next asked whether environmental stressors may lead to individual differences in wild-type mice in the response to CUS upon mood-related behavioral traits. We found that CUS exposure resulted in significant differences in coat-state deterioration at the coat-state rating scale ( Figure 2b ) between what we designated as HS and LS mice (Figure 2d and e). No differences in weight gain between HS and LS mice were observed ( Figure 2c ).
We then assessed natural reward preference and behavioral despair (Figure 2a ) using, respectively, the sucrose preference test and the FST. Anhedonia is a hallmark symptom of major depressive disorder that in rodents is evaluated by a decrease in the preference for a sucrose solution compared with water at the sucrose preference test (SPT). Remarkably, CUS-HS-mice showed a deficit in natural reward in the sucrose preference test and an increase in the immobility time at the FST compared with CUS-LS mice. In contrast, CUS-LS mice showed no difference in sucrose intake and in immobility time at the FST compared with unstressed mice (Figure 2f and g).
Hippocampal mGlu2 impairment in HS mice: a molecular signature of stress susceptibility Next, we inquired whether stress susceptible (HS) and resilient mice (LS) differ in their expression of mGlu2 receptors within the hippocampus and PFC. Notably, CUS-HS mice showed a significantly lower expression of mGlu2 receptor within the hippocampus compared with CUS-LS mice (Figure 2h and i). No difference in hippocampal mGlu2 receptor expression was detected between CUS-LS-mice and unstressed mice. Furthermore, both CUS-LS and CUS-HS mice showed a substantial 82% lower mGlu2 receptor expression within the PFC compared with control mice (Figure 2j and k) and thus PFC mGlu2 expression does not distinguish between LS and HS mice.
ARS results in behavioral and molecular individual differences that are reminiscent of the HS and LS endophenotypes induced by CUS To determine whether individual differences could be detected also after acute stress of naïve mice, we evaluated the response to an ARS ( Figure 3a ) paradigm assessing anxiety-related behavior and examining resultant effects on mGlu2 transcript levels. After ARS, we were able to distinguish what appears to be HS mice, which, as a group, showed a 37% decrease in the time spent in the light chamber at the LDT 26 compared with another group of mice that we designated as LS because they showed only a 9% decrease (Figure 3b and c). Moreover, among these mice, acute stress behavioral effects correlated with a strong 64% and a mild 6% downregulation in mGlu2 transcript levels within the hippocampus of HS and LS mice, respectively, whereas no change was found in PFC after ARS (Figure 3d) . A Spearman's correlation analysis showed a substantial positive correlation of hippocampal mGlu2 mRNA levels and time spent in the light chamber at the LDT in HS and LS mice (Figure 3e ).
MRs regulate the stress-induced impairment in mGlu2 receptor through a p300-driven epigenetic mechanism Since glucocorticoids play a pivotal role in regulating the tone of the stressed glutamatergic synapse, 15 we measured the levels of MR and GR transcripts in LS and HS mice. After ARS and the LDT, LS mice showed lower MR hippocampal transcripts compared with HS mice (Figure 4a ) and no difference in hippocampal GR transcript levels (Figure 4a ). No change in MR or GR levels was found between LS and HS mice within the PFC (Figure 4b ). Spearman's correlation analyses show a large negative correlation of hippocampal MR mRNA levels and time spent in the light chamber at the LDT in HS and LS mice ( Figure 4c ) and a large negative correlation of hippocampal mGlu2 mRNA levels and MR mRNA levels (Figure 4d ). Furthermore, we wondered whether reduced MR transcripts in resilient LS mice might be lower compared with HS mice because of an effect of earlier 'non-shared' experiences (for example, differential exposure to maternal care). Thus, we screened an inbred population of C57bl mice using the LDT screening method for HS vs LS mice without any prior acute stress ( Figure 4f ) and we measured MR and mGlu2 transcripts in hippocampus. We killed animals immediately after the end of the LDT to minimize any effects due to the minimal stress manipulation (Figure 4e ). Interestingly, the naïve mouse subgroup that we designed as naïve LS mice, based upon lower scores in the LDT, show reduced MR transcripts in hippocampus compared with the naïve mouse subgroup that we designed as naïve HS mice (Figure 4g) . No difference in mGlu2 transcripts was found in these stress-naive mice (Figure 4g ) suggesting that MR levels are markers of the anxiety level in the LDT and might mediate the stress-induced reduction of mGlu2 expression.
To establish the selective inhibitory role of MR activation on mGlu2 transcription, we tested the effects of the selective MR antagonist, spironolactone, as well as the selective GR antagonist, RU486, which were administered 3 h prior to an acute episode of restraint stress (Figure 5a ). We did so on naïve C57bl mice without sorting into LS and HS animals, and we found that either the combination of GR and MR antagonists, or the injection of spironolactone alone, blocked the acute stress-induced downregulation of mGlu2 receptors within the hippocampus (Figure 5b ). As expected, because of the likely presence of both LS and HS mice, there was scatter in the data ( Supplementary  Figure 1 ), but the overall spironolactone effect was highly significant and would undoubtedly have been higher had we used only HS mice. Thus, MR activation mediates an inhibition of mGlu2 transcription, whereas RU486, in a dose sufficient to alter spine synapse turnover in mouse cortex, 25 was unable to block the rapid stress effect on mGlu2 transcript levels (Figure 5b) . In e, f, bars represent mean+s.e.m., *indicate significant comparisons, **Po 0.01, ***P o0.001. (h) In the hippocampus, the relationship between MR and mGlu2 mRNA levels can be described by a quadratic curve that models the epigenetic allostasis concept described in the text.
To explore the possible mechanistic link of stressors to an epigenetic control of the glutamatergic synapse, a second series of studies was carried out, again on naïve C57bl mice without selection for HS or LS endophenotype. Here, using chromatin immunoprecipitation assay, we found that spironolactone, in contrast to RU486, blocked the stress-induced decrease in the level of H3K27ac, a transcriptional activity marker bound to the GRM2 promoter gene that regulates mGlu2 expression ( Figure 5c ). This occurs, at least in part, through the prevention by spironolactone of the stress-induced decrease in the acetyltransferase (HAT) p300 (Figure 5d ), revealing a selective MR-mediated epigenetic control of the mGlu2 receptor. Moreover, in contrast to RU486, spironolactone also blocked the acute stress-induced anxiety behavior in the LDT (Figure 5e ). Thus, a rapid epigenetic action of GRs via MR appears to be involved in the acute stress effects on anxiety-related behavior and mGlu2 transcript downregulation in hippocampus.
DISCUSSION
A same event may be more or less stressful or have pathophysiological consequences for one individual compared with another depending on prior experiences even when the genotype is similar or identical, as for identical twins 1 or genetically homogeneous mice. 2 Our findings show that both chronic unpredictable stress and ARS results in individual differences in an inbred population of wild-type mice that are more HS or LS to stressinduced mood abnormalities as measured by tests of depressionand anxiety-related behaviors and coat appearance. HS mice, reflecting a more anxiety-prone trajectory of development, show a Figure 5 . Glucocorticoids, via MR receptors, link stressful experience to an epigenetic control of the glutamatergic synapse. (a) Time course and design of the treatments with the selective GR and MR antagonists. (b) Spironolactone (20 mg kg − 1 , i.p.) alone or in combination with RU486 (also known as mifepristone, 20 mg kg − 1 , i.p.), but not RU486 alone, administered 3 hr before the stress exposure blocks the stressinduced decrease in mGlu2 mRNA transcript levels in the hippocampus of ARS mice (c), chromatin immunoprecipitation assay shows that spironolactone, but not RU486, blocks the stress-induced decrease in H3K27ac bound to the Grm2 promoter gene within the hippocampus. (d) Spironolactone abolishes ARS reduction in the HAT p300 mRNA levels. (e) Spironolactone, but not RU486, blocks the ARS-induced anxietyrelated behavior at the light-dark test. Bars represent mean+s.e.m., *indicate significant comparisons with control groups, *Po 0.05, **P o0.01, ***P o0.0001. deficit in natural reward and behavioral despair after CUS (depressive-like hippocampus). Indeed, mGlu2-knockout mice mimic the behavioral responses shown by the HS endophenotype. Similarly, wild-type mice subjected to ARS and subdivided into HS and LS mice using the rapid screening method introduced here, show individual differences in anxiety-related behavior in a LDT and display reduced mGlu2 expression in hippocampus; this is reminiscent of the HS and LS endophenotypes induced by the more prolonged CUS. Thus, after both ARS and CUS, stresssusceptible HS mice are recognized by having reduced mGlu2 expression in hippocampus, while PFC mGlu2 expression does not distinguish between HS and LS subtypes.
Mechanistically, glucocorticoids enter the brain and bind to two subtypes of receptors, the higher-affinity MR and the lower-affinity GR, which are both highly expressed within the hippocampal formation. 28, 29 There, they orchestrate physiological stress responses aimed at maintaining homeostasis through both delayed genomic and rapid non-genomic mechanisms. 15, 30 We show here that acute stress effects on behavior and mGlu2 transcripts in hippocampus are blocked by spironolactone, a selective MR antagonist, thus implicating rapid action of glucocorticoids via a receptor that is known to activate rapid glutamate release. 31 Indeed, presynaptic mGlu2 receptors exert an inhibitory tone on glutamate release into the synaptic space. Perhaps one of the most striking aspects of our results is that the HS mice display higher hippocampal MR transcripts compared with the resilient LS mice and, consequently, an increased effect of stress-induced suppression of hippocampal mGlu2 receptors.
Glutamatergic inputs to pyramidal neurons in the PFC and hippocampus play a critical role in the maintenance of homeostasis in the face of stressful life events, which require adaptive responses involving changes in the central nervous and neuroendocrine systems. The hippocampus and PFC are interconnected and influence each other via direct and indirect neural activity in the control of stress responses. 32 The hippocampus mediates contextual and temporal aspects of stress-related memory as well as mood-related behaviors, whereas the PFC is mainly involved in decision making, self-regulatory behaviors and extinction processes. 33, 34 Together with our previous data showing an epigenetic upregulation of mGlu2 receptors induced by the fastacting antidepressant acetyl-L-carnitine, 16, 21, 22 the results of the present study lead us to hypothesize that a downregulation of mGlu2 receptor in hippocampus of HS animals, but not the reduction that also occurs in PFC after CUS, is a critical event that increases susceptibility to stress to impair mood-related behaviors.
The reduction in mGlu2 inhibitory tone in hippocampus leads to an imbalance in relation to the role of the PFC and hippocampus in regulating those behaviors. Indeed, CUS-resilient LS mice, which show selective mGlu2 receptor downregulation within the PFC, but not in hippocampus, are better able to resist stressors. Hence, the ability of LS mice to perceive stressful events in less threatening ways may be mediated by promoting adaptive coping strategies to sustain mGlu2 receptor expression within the hippocampus. Thus, such resilience may be an active strategy to assure normal excitatory input within the hippocampus through the presynaptic control of mGlu2 receptors on glutamate release. This active neurobiological process in resilient LS mice is reminiscent of previous findings that showed differential changes in gene expression in unsusceptible mice compared with susceptible mice after social defeat stress. 35 One attractive hypothesis for future research on the role of hippocampus in stress responsivity is that there is a defect in a counter-regulatory mechanism in the crosstalk between glucocorticoids and glutamate, such as alterations in the endocannabinoid system that regulates glutamate release. 15, 36 How then does MR activation lead to reduced mGlu2 expression? Epigenetically, as shown by chromatin immunoprecipitation assay analysis and expression of the HAT p300 enzyme, the MR-mediated effect in hippocampus of ARS mice involves inhibition of the HAT p300-driven acetylation of the H3K27, a transcriptional active mark bound to the GRM2 promoter gene, which regulates expression of the mGlu2 receptor. Thus, glucocorticoids acting via MRs orchestrate neuronal excitability through a crosstalk with the mGlu2 receptor, which is the presynaptic metabotropic glutamate receptor that inhibits glutamate release into the synaptic space. Based upon the finding that early-life stress alters methylation of CpG residues in the GR promoter resulting in a variable vulnerability to stress and anxious traits, 29 one possibility to explain the present findings on MR would be an epigenetic modification of the MR promoter induced by early-life events. This is a topic for future investigation.
Recently, preclinical studies have shown that juvenile stress increases hippocampal MR mRNA levels and anxiety-like behavior in adulthood 37 and thus differential early-life experiences may determine levels of MR expression. Here, we were able to show that higher baseline MR mRNA levels, obtained immediately after a light-dark anxiety test without any prior acute stress, characterize the difference between HS and LS mice. These individual differences are reminiscent of reports that show that individual differences in anxiety-related behavior in rats, found early in life, can predict lifespan 3 as well as cortical dendritic morphology. 4 Also, our findings demand a better understanding of how 'non-shared' experiences 2 determine individual behavioral responses via epigenetic mechanisms. Mother-infant interactions are key factors in emotional and cognitive development, and good or poor maternal care of newborn offspring is a well-known determinant of adult emotionality 38 via epigenetic modifications of specific sets of genes such as the GR. 39 Yet, even among 'good' and 'poor' maternal care, there are variations in offspring outcome due to individual experiences of those offspring related to the consistency of that maternal care ('attachment'), as well as the supply of nutrients and the exposure to a novelty. 38, 40 Such 'nonshared' experiences even among genetically identical offspring set each individual on a somewhat different trajectory of development, determining individual responses to subsequent novel experiences as potential stressors including exploratory behavior in the living environment. 2 Our findings provide a model at the molecular level to better understand the adaptive role of glucocorticoids and their receptors. 41 Epigenetic allostasis (Figure 4h) incorporates an epigenetic core into the allostasis-allostatic load model of stress and adaptation. 41 In the case of MR and its regulation of mGlu2, the levels of MR and mGlu2 fit a quadratic MR-dependent curve reflecting the consequences of 'non-shared' experiences that can program each individual via expression of MR to a somewhat different trajectory of development as far as responses (behavior, physiology and susceptibility to disease) to subsequent stressful life experiences. Epigenetic allostasis implies that epigenetic changes induced by early-life experiences bias the individual to responses to future stressful life events that may be adaptive under some circumstances (for example, anxiety and vigilance in a dangerous environment with higher MR) or maladaptive (proneness to develop anxiety or depressive disorders with higher MR) under others.
Together, these results suggest that the individual responsivity to stress, perhaps as a result of developmentally arising individual differences in neuronal hippocampal activity, may predict longterm consequences of social stress and susceptibility to moodrelated behaviors. In particular, we have demonstrated individual differences in HS vs LS mice in the ability of stress to induce a decrease in hippocampal mGlu2 receptor expression. mGlu2 reductions appear to operate through a rapid 31, 42 MR-mediated epigenetic mechanism. Reductions in hippocampal mGlu2 levels may give rise to increased glutamate release and glutamatergic hyperactivity, supporting previous evidence that stress rapidly increases glutamate release in hippocampal pyramidal neurons through a non-genomic mechanism mediated by MR receptors. 19 Such hyperactivity is also associated with dendritic shrinkage and suppressed dentate gyrus neurogenesis and dysregulated moodrelated behaviors. 15 Exploring the means, pharmacological or behavioral, to prevent the stress-induced decrease of mGlu2 43, 44 in hippocampus is a potential new direction in managing negative effects of stressful experiences in susceptible individuals.
